Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms
DRKS00020940Phase 3Completed
- Sponsor
- German Cancer Research Center
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aspirin in colon neoplasm, colon cancer, rectosigmoid cancer and 1 more, sponsored by German Cancer Research Center. Primary endpoint: Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms. Started Oct 2020; status: completed.
02
Drugs
aspirin
03
Conditions
colon neoplasmcolon cancerrectosigmoid cancerrectal cancer
Beyond the preview
Go deeper on DRKS00020940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020940.